Arlington Financial Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.88M Sell
43,987
-2,552
-5% -$283K 0.8% 32
2025
Q1
$5.21M Sell
46,539
-481
-1% -$53.9K 0.92% 30
2024
Q4
$4.34M Buy
47,020
+915
+2% +$84.5K 0.86% 35
2024
Q3
$3.87M Buy
46,105
+64
+0.1% +$5.37K 0.79% 35
2024
Q2
$3.16M Buy
46,041
+1,240
+3% +$85.1K 0.69% 37
2024
Q1
$3.28M Buy
44,801
+1,678
+4% +$123K 0.72% 37
2023
Q4
$3.49M Buy
43,123
+39
+0.1% +$3.16K 1.04% 31
2023
Q3
$3.23M Buy
43,084
+341
+0.8% +$25.6K 1.14% 28
2023
Q2
$3.29M Buy
42,743
+2
+0% +$154 1.2% 26
2023
Q1
$3.55M Sell
42,741
-6,442
-13% -$534K 1.37% 20
2022
Q4
$4.22M Sell
49,183
-171
-0.3% -$14.7K 1.78% 16
2022
Q3
$3.05M Sell
49,354
-3,464
-7% -$214K 1.55% 19
2022
Q2
$3.27M Buy
52,818
+1,255
+2% +$77.6K 1.47% 18
2022
Q1
$3.07M Buy
51,563
+148
+0.3% +$8.8K 1.16% 29
2021
Q4
$3.73M Buy
51,415
+587
+1% +$42.6K 1.26% 23
2021
Q3
$3.55M Buy
50,828
+201
+0.4% +$14K 1.39% 25
2021
Q2
$3.49M Buy
50,627
+16,700
+49% +$1.15M 1.32% 26
2021
Q1
$2.19M Buy
33,927
+26,438
+353% +$1.71M 0.89% 33
2020
Q4
$436K Sell
7,489
-27,922
-79% -$1.63M 0.18% 51
2020
Q3
$2.24M Buy
35,411
+229
+0.7% +$14.5K 1.15% 26
2020
Q2
$2.71M Buy
35,182
+917
+3% +$70.6K 1.53% 20
2020
Q1
$2.56M Buy
34,265
+7,658
+29% +$573K 1.82% 16
2019
Q4
$1.73M Sell
26,607
-12,232
-31% -$795K 0.96% 31
2019
Q3
$2.46M Buy
38,839
+906
+2% +$57.4K 1.41% 23
2019
Q2
$2.56M Buy
37,933
+854
+2% +$57.7K 1.47% 22
2019
Q1
$2.41M Buy
37,079
+3,773
+11% +$245K 1.37% 25
2018
Q4
$2.08M Sell
33,306
-753
-2% -$47.1K 0.89% 35
2018
Q3
$2.42M Buy
34,059
+174
+0.5% +$12.4K 1.45% 22
2018
Q2
$2.64M Buy
33,885
+7,294
+27% +$568K 1.53% 20
2018
Q1
$1.98M Buy
26,591
+440
+2% +$32.7K 1.3% 22
2017
Q4
$2.13M Buy
+26,151
New +$2.13M 1.01% 25